NSE files ₹30,000 crore DRHP for India's biggest IPO
National Stock Exchange filed a DRHP for a ₹30,000 crore Offer for Sale, set to be India's largest IPO. The issue involves 148.9 million shares from existing shareholders and will list on BSE. NSE reported revenue of ₹16,601 crore and net profit of ₹10,302 crore in FY26.

*this image is generated using AI for illustrative purposes only.
National Stock Exchange filed its Draft Red Herring Prospectus with SEBI on June 17, 2026, for an estimated ₹30,000 crore initial public offering. The Offer for Sale of up to 148.9 million shares represents nearly 6% of the company and is expected to become India's largest IPO, surpassing the ₹27,858.80 crore issue by Hyundai Motor India. The shares will list on BSE, as regulations prohibit an exchange from listing on its own platform.
The IPO proceeds will go entirely to existing shareholders, including SBI, Morgan Stanley, and Canada Pension Plan Investment Board, as NSE will not receive any funds. LIC, the single largest shareholder with a 10.72% stake, is not participating in the sale. The issue is managed by a syndicate of investment bankers, including Kotak Mahindra Capital and Morgan Stanley India.
NSE's journey to the public markets follows a ₹1,300 crore settlement with SEBI in January 2026 over a co-location controversy, which had previously derailed its 2016 listing attempt. The board approved the fresh DRHP filing on February 6, 2026. The exchange, incorporated in 1992, eliminated manual trading by 1999 and launched its derivatives segment in 2000.
In FY26, NSE retained its position as the world's largest equity derivatives exchange, handling 51.18% of global equity derivatives contracts. Its share of global cash equity trades stood at 11.38%. Financial performance for the year showed a 3% decline in revenue to ₹16,601 crore and a 15% drop in net profit to ₹10,302 crore.
Ownership of NSE is subject to strict regulations to prevent concentration of control. No foreign or domestic entity can own more than 5% without regulatory approval, though banks and insurance companies can hold up to 15%. The proposed IPO offers investors a stake in an exchange that dominates the Indian cash market and ranks third globally by cash equity trades.
How will the IPO pricing be affected by the 3% revenue decline and 15% profit drop reported in FY26?
What is the expected timeline for regulatory approval and the final launch of the offer following the DRHP filing?
Will the exclusion of LIC from the Offer for Sale impact retail investor demand given its status as the largest shareholder?

























